http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108434161-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4710445fd320126d7d3004bc8a30925e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5800ff080482e7743ac4f376b4f5c6bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d11986ac8db22308d3d3d0c68f78f29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_546602f003e31f22069beceac8e7627f
publicationDate 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108434161-A
titleOfInvention 2-acetylamino-2-deoxy-D-glucose or its officinal salt are preparing application and drug, health products in treating tumour drug
abstract The present invention provides a kind of N acetyl D Glucosamines or its officinal salt and is preparing application and drug, health products in treating tumour drug, is related to field of medicaments.N acetyl D Glucosamines provided by the invention are preparing the application in treating tumour drug, and application of the N acetyl D Glucosamines in preparing tumour health products, tumour can be effectively treated or alleviate by active ingredient N acetyl D Glucosamines, treatment cycle is short, has no toxic side effect.
priorityDate 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65533
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SR52
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB9GCH9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4432340
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID36606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439213
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS23
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07374
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00084
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE0ZS48
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426033928
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A3P9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS22
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID36606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457588632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583531

Total number of triples: 42.